Hillsdale Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-70
| Closed | -$11K | – | 712 |
|
|
2020
Q4 | $11K | Sell |
70
-4,500
| -98% | -$707K | ﹤0.01% | 492 |
|
|
2020
Q3 | $523K | Buy |
4,570
+100
| +2% | +$11.4K | 0.05% | 308 |
|
|
2020
Q2 | $502K | Hold |
4,470
| – | – | 0.05% | 318 |
|
|
2020
Q1 | $401K | Buy |
4,470
+100
| +2% | +$8.97K | 0.05% | 329 |
|
|
2019
Q4 | $473K | Hold |
4,370
| – | – | 0.04% | 374 |
|
|
2019
Q3 | $428K | Buy |
+4,370
| New | +$428K | 0.04% | 383 |
|
|
2018
Q1 | – | Sell |
-3,000
| Closed | -$359K | – | 552 |
|
|
2017
Q4 | $359K | Buy |
+3,000
| New | +$359K | 0.06% | 268 |
|
|
2015
Q2 | – | Sell |
-510
| Closed | -$88K | – | 571 |
|
|
2015
Q1 | $88K | Sell |
510
-1,400
| -73% | -$242K | 0.02% | 420 |
|
|
2014
Q4 | $353K | Sell |
1,910
-100
| -5% | -$18.5K | 0.09% | 191 |
|
|
2014
Q3 | $333K | Hold |
2,010
| – | – | 0.11% | 157 |
|
|
2014
Q2 | $314K | Buy |
2,010
+510
| +34% | +$79.7K | 0.07% | 203 |
|
|
2014
Q1 | $228K | Buy |
+1,500
| New | +$228K | 0.06% | 287 |
|